MND-SMART Trial update

trial participant in discussion with a research nurse

Apr 2022: Stage 1 analysis of memantine and trazodone.

Our independent trial committee recently reviewed stage 1 data for the drugs we are currently testing in MND-SMART.

The outcome was that we should continue testing both memantine and trazodone, collecting data to determine whether either drug slows down the progression of MND.

In this video we provide an update on the outcomes and what this means for our participants.

This article was published on: Tuesday, 5 April, 2022